| PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor L Da Dalt, M Ruscica, F Bonacina, G Balzarotti, A Dhyani, E Di Cairano, ... European heart journal 40 (4), 357-368, 2019 | 172 | 2019 |
| Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation F Bonacina, D Coe, G Wang, MP Longhi, A Baragetti, A Moregola, ... Nature communications 9 (1), 3083, 2018 | 115 | 2018 |
| Cholesterol metabolism, pancreatic β-cell function and diabetes C Perego, L Da Dalt, A Pirillo, A Galli, AL Catapano, GD Norata Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (9 …, 2019 | 105 | 2019 |
| PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction L Da Dalt, L Castiglioni, A Baragetti, M Audano, M Svecla, F Bonacina, ... European Heart Journal 42 (32), 3078-3090, 2021 | 69 | 2021 |
| Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures M Gomaraschi, AL Fracanzani, P Dongiovanni, C Pavanello, E Giorgio, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2019 | 29 | 2019 |
| Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models A Daci, L Da Dalt, R Alaj, S Shurdhiqi, B Neziri, R Ferizi, G Danilo Norata, ... PLoS One 15 (12), e0240669, 2020 | 20 | 2020 |
| Mannose receptor deficiency impacts bone marrow and circulating immune cells during high fat diet induced obesity J Nour, A Moregola, M Svecla, L Da Dalt, R Bellini, O Neyrolles, GP Fadini, ... Metabolites 12 (12), 1205, 2022 | 16 | 2022 |
| Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis F Bonacina, L Da Dalt, AL Catapano, GD Norata Molecular aspects of medicine 77, 100918, 2021 | 15 | 2021 |
| Cardiac lipid metabolism, mitochondrial function, and heart failure L Da Dalt, AG Cabodevilla, IJ Goldberg, GD Norata Cardiovascular Research 119 (10), 1905-1914, 2023 | 14 | 2023 |
| Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis A Marku, L Da Dalt, A Galli, N Dule, P Corsetto, AM Rizzo, A Moregola, ... Metabolism 136, 155291, 2022 | 14 | 2022 |
| Cameroonian spice extracts modulate molecular mechanisms relevant to cardiometabolic diseases in SW 872 Human liposarcoma cells AP Atchan Nwakiban, A Passarelli, L Da Dalt, C Olivieri, TN Demirci, ... Nutrients 13 (12), 4271, 2021 | 8 | 2021 |
| Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib F Guerra, S Gasperini, S Bonanomi, V Crescitelli, R Pretese, L Da Dalt, ... EJHaem 4 (2), 551, 2023 | 7 | 2023 |
| Neutrophil aging exacerbates high fat diet induced metabolic alterations A Baragetti, L Da Dalt, A Moregola, M Svecla, O Terenghi, E Mattavelli, ... Metabolism 144, 155576, 2023 | 5 | 2023 |
| Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors A Baragetti, F Bonacina, L Da Dalt, A Moregola, V Zampoleri, F Pellegatta, ... European Journal of Preventive Cardiology 29 (5), 721-729, 2022 | 5 | 2022 |
| The inhibition of inner mitochondrial fusion in hepatocytes reduces non-alcoholic fatty liver and improves metabolic profile during obesity by modulating bile acid conjugation L Da Dalt, A Moregola, M Svecla, S Pedretti, F Fantini, M Ronzio, P Uboldi, ... Cardiovascular Research 119 (18), 2917-2929, 2023 | 3 | 2023 |
| The inhibition of inner mitochondrial fusion in hepatocytes reduces NAFL and improves metabolic profile during obesity by modulating bile acid conjugation. L Da Dalt, A Moregola, M Svecla, S Pedretti, F Fantini, M Ronzio, P Uboldi, ... Cardiovascular Research, cvad169-cvad169, 2023 | 2 | 2023 |
| Role of lysosomal acid lipase in PPAR-mediated reduction of lipid accumulation in hepatocytes A Ossoli, S Frascarelli, L Da Dalt, GD Norata, L Calabresi, M Gomaraschi Atherosclerosis 355, 20, 2022 | 1 | 2022 |
| PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the LDL receptor L Da Dalt, M Ruscica, F Bonacina, A Baragetti, C Perego, A Catapano, ... Atherosclerosis Supplements 32, 21, 2018 | 1 | 2018 |
| New insights into the therapeutic options to lower lipoprotein (a) A Baragetti, L Da Dalt, GD Norata European Journal of Clinical Investigation, e14254, 2024 | | 2024 |
| Unraveling the metabolic pattern of angiopoietin-like 3 knock-out mouse models under fasting and fed conditions O Terenghi, L Da Dalt, F Fantini, A Moregola, F Bonacina, GD Norata Cardiovascular Research 120 (Supplement_1), cvae088. 197, 2024 | | 2024 |
